Oleg A. Barski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Oleg A. Barski has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
Aruni Bhatnagar
From the Diabetes and Obesity Center, School of Medicine, University of Louisville, Louisville, KY
10 shared publicationsKenneth H. Gabbay
Baylor College of Medicine, Houston, TX, USA
6 shared publicationsSrinivas M. Tipparaju
Diabetes and Obesity Center, University of Louisville, Louisville, KY 40202, United States
6 shared publications- Kurt Max Bohren
Department of Pathology and Immunology, Baylor College of Medicine
5 shared publications Sanjay Srivastava
From the Diabetes and Obesity Center, School of Medicine, University of Louisville, Louisville, KY
5 shared publications- Aruni Bhatnagar
Christina Lee Brown Envirome Institute, School of Medicine, University of Louisville, 302 E Muhammad Ali Blvd, Louisville, KY, 40202, USA; Department of Medicine, School of Medicine, University of Louisville, 550 S. Jackson St, Louisville, KY, 40202, USA
3 shared publications
Latest Publications
- 1 October 2017
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 276, 182-193
Characterization of AKR1B16, a novel mouse aldo-keto reductase
- 1 October 2017
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 276, 182-193
Characterization of AKR1B16, a novel mouse aldo-keto reductase
- 1 June 2013
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 33 (6) , 1162-1170
Dietary Carnosine Prevents Early Atherosclerotic Lesion Formation in Apolipoprotein E–Null Mice
Objective—: Atherosclerotic lesions are associated with the accumulation of reactive aldehydes derived from oxidized lipids. Although inhibition of aldehyde metabolism has been shown to exacerbate atherosclerosis and enhance the accumulation of aldehyde-modified proteins in atherosclerotic plaques, no therapeutic interventions have been devised to prevent aldehyde accumulation in atherosclerotic lesions. Approach and Results—: We examined the efficacy of carnosine, a naturally occurring β-alanyl-histidine dipeptide, in preventing aldehyde toxicity and atherogenesis in apolipoprotein E–null mice. In vitro, carnosine reacted rapidly with lipid peroxidation-derived unsaturated aldehydes. Gas chromatography mass-spectrometry analysis showed that carnosine inhibits the formation of free aldehydes 4-hydroxynonenal and malonaldialdehyde in Cu 2+ -oxidized low-density lipoprotein. Preloading bone marrow–derived macrophages with cell-permeable carnosine analogs reduced 4-hydroxynonenal–induced apoptosis. Oral supplementation with octyl-D-carnosine decreased atherosclerotic lesion formation in aortic valves of apolipoprotein E–null mice and attenuated the accumulation of protein-acrolein, protein-4-hydroxyhexenal, and protein-4-hydroxynonenal adducts in atherosclerotic lesions, whereas urinary excretion of aldehydes as carnosine conjugates was increased. Conclusions—: The results of this study suggest that carnosine inhibits atherogenesis by facilitating aldehyde removal from atherosclerotic lesions. Endogenous levels of carnosine may be important determinants of atherosclerotic lesion formation, and treatment with carnosine or related peptides could be a useful therapy for the prevention or the treatment of atherosclerosis.
- 1 June 2013
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 33 (6) , 1162-1170
Dietary Carnosine Prevents Early Atherosclerotic Lesion Formation in Apolipoprotein E–Null Mice
Objective—: Atherosclerotic lesions are associated with the accumulation of reactive aldehydes derived from oxidized lipids. Although inhibition of aldehyde metabolism has been shown to exacerbate atherosclerosis and enhance the accumulation of aldehyde-modified proteins in atherosclerotic plaques, no therapeutic interventions have been devised to prevent aldehyde accumulation in atherosclerotic lesions. Approach and Results—: We examined the efficacy of carnosine, a naturally occurring β-alanyl-histidine dipeptide, in preventing aldehyde toxicity and atherogenesis in apolipoprotein E–null mice. In vitro, carnosine reacted rapidly with lipid peroxidation-derived unsaturated aldehydes. Gas chromatography mass-spectrometry analysis showed that carnosine inhibits the formation of free aldehydes 4-hydroxynonenal and malonaldialdehyde in Cu 2+ -oxidized low-density lipoprotein. Preloading bone marrow–derived macrophages with cell-permeable carnosine analogs reduced 4-hydroxynonenal–induced apoptosis. Oral supplementation with octyl-D-carnosine decreased atherosclerotic lesion formation in aortic valves of apolipoprotein E–null mice and attenuated the accumulation of protein-acrolein, protein-4-hydroxyhexenal, and protein-4-hydroxynonenal adducts in atherosclerotic lesions, whereas urinary excretion of aldehydes as carnosine conjugates was increased. Conclusions—: The results of this study suggest that carnosine inhibits atherogenesis by facilitating aldehyde removal from atherosclerotic lesions. Endogenous levels of carnosine may be important determinants of atherosclerotic lesion formation, and treatment with carnosine or related peptides could be a useful therapy for the prevention or the treatment of atherosclerosis.
- 1 February 2013
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 202 (1-3) , 288-297
Detoxification of aldehydes by histidine-containing dipeptides: From chemistry to clinical implications
- 1 February 2013
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 202 (1-3) , 288-297
Detoxification of aldehydes by histidine-containing dipeptides: From chemistry to clinical implications
- 5 January 2013
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 202 (1-3) , 153-158
Alternative splicing in the aldo–keto reductase superfamily: Implications for protein nomenclature
- 5 January 2013
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 202 (1-3) , 153-158
Alternative splicing in the aldo–keto reductase superfamily: Implications for protein nomenclature
- 17 March 2012
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 463 (6) , 799-818
Interactions between the C-terminus of Kv1.5 and Kvβ regulate pyridine nucleotide-dependent changes in channel gating
Voltage-gated potassium (Kv) channels are tetrameric assemblies of transmembrane Kv proteins with cytosolic N- and C-termini. The N-terminal domain of Kv1 proteins binds to β-subunits, but the role of the C-terminus is less clear. Therefore, we studied the role of the C-terminus in regulating Kv1.5 channel and its interactions with Kvβ-subunits. When expressed in COS-7 cells, deletion of the C-terminal domain of Kv1.5 did not affect channel gating or kinetics. Coexpression of Kv1.5 with Kvβ3 increased current inactivation, whereas Kvβ2 caused a hyperpolarizing shift in the voltage dependence of current activation. Inclusion of NADPH in the patch pipette solution accelerated the inactivation of Kv1.5-Kvβ3 currents. In contrast, NADP+ decreased the rate and the extent of Kvβ3-induced inactivation and reversed the hyperpolarizing shift in the voltage dependence of activation induced by Kvβ2. Currents generated by Kv1.5ΔC+Kvβ3 or Kv1.5ΔC+Kvβ2 complexes did not respond to changes in intracellular pyridine nucleotide concentration, indicating that the C-terminus is required for pyridine nucleotide-dependent interactions between Kvβ and Kv1.5. A glutathione-S-transferase (GST) fusion protein containing the C-terminal peptide of Kv1.5 did not bind to apoKvβ2, but displayed higher affinity for Kvβ2:NADPH than Kvβ2:NADP+. The GST fusion protein also precipitated Kvβ proteins from mouse brain lysates. Pull-down experiments, structural analysis and electrophysiological data indicated that a specific region of the C-terminus (Arg543-Val583) is required for Kvβ binding. These results suggest that the C-terminal domain of Kv1.5 interacts with β-subunits and that this interaction is essential for the differential regulation of Kv currents by oxidized and reduced nucleotides.
- 17 March 2012
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 463 (6) , 799-818
Interactions between the C-terminus of Kv1.5 and Kvβ regulate pyridine nucleotide-dependent changes in channel gating
Voltage-gated potassium (Kv) channels are tetrameric assemblies of transmembrane Kv proteins with cytosolic N- and C-termini. The N-terminal domain of Kv1 proteins binds to β-subunits, but the role of the C-terminus is less clear. Therefore, we studied the role of the C-terminus in regulating Kv1.5 channel and its interactions with Kvβ-subunits. When expressed in COS-7 cells, deletion of the C-terminal domain of Kv1.5 did not affect channel gating or kinetics. Coexpression of Kv1.5 with Kvβ3 increased current inactivation, whereas Kvβ2 caused a hyperpolarizing shift in the voltage dependence of current activation. Inclusion of NADPH in the patch pipette solution accelerated the inactivation of Kv1.5-Kvβ3 currents. In contrast, NADP+ decreased the rate and the extent of Kvβ3-induced inactivation and reversed the hyperpolarizing shift in the voltage dependence of activation induced by Kvβ2. Currents generated by Kv1.5ΔC+Kvβ3 or Kv1.5ΔC+Kvβ2 complexes did not respond to changes in intracellular pyridine nucleotide concentration, indicating that the C-terminus is required for pyridine nucleotide-dependent interactions between Kvβ and Kv1.5. A glutathione-S-transferase (GST) fusion protein containing the C-terminal peptide of Kv1.5 did not bind to apoKvβ2, but displayed higher affinity for Kvβ2:NADPH than Kvβ2:NADP+. The GST fusion protein also precipitated Kvβ proteins from mouse brain lysates. Pull-down experiments, structural analysis and electrophysiological data indicated that a specific region of the C-terminus (Arg543-Val583) is required for Kvβ binding. These results suggest that the C-terminal domain of Kv1.5 interacts with β-subunits and that this interaction is essential for the differential regulation of Kv currents by oxidized and reduced nucleotides.
- Open Access
- 1 December 2011
- Published by Elsevier in Journal of Lipid Research
- Vol. 52 (12) , 2209-2225
Reductive metabolism increases the proinflammatory activity of aldehyde phospholipids
- 1 December 2011
- Published by Elsevier in Journal of Lipid Research
- Vol. 52 (12) , 2209-2225
Open AccessReductive metabolism increases the proinflammatory activity of aldehyde phospholipids
- 1 May 2011
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 191 (1-3) , 255-260
Catalytic reduction of carbonyl groups in oxidized PAPC by Kvβ2 (AKR6)
- 1 May 2011
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 191 (1-3) , 255-260
Catalytic reduction of carbonyl groups in oxidized PAPC by Kvβ2 (AKR6)
- 1 May 2011
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 191 (1-3) , 177-184
Functional expression of novel human and murine AKR1B genes
- 1 May 2011
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 191 (1-3) , 177-184
Functional expression of novel human and murine AKR1B genes
- 1 February 2010
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 243 (1) , 1-12
Acrolein consumption induces systemic dyslipidemia and lipoprotein modification
- 1 February 2010
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 243 (1) , 1-12
Acrolein consumption induces systemic dyslipidemia and lipoprotein modification
- 31 January 2010
- Published by Elsevier in Biophysical Journal
- Vol. 98 (3) , 523a-523
Pyridine Nucleotide Dependence of Kv Beta - Induced Kv Inactivation: Role of Kv Alpha C-Terminus
- 31 January 2010
- Published by Elsevier in Biophysical Journal
- Vol. 98 (3) , 523a-523
Pyridine Nucleotide Dependence of Kv Beta - Induced Kv Inactivation: Role of Kv Alpha C-Terminus